Prospective Pilot Study on Metabolism and Weight Changes in Topiramate-Treated Epilepsy Patients
Clinical trial NCT00236886 · COMPLETED
Trial details
- NCT number
- NCT00236886
- Sponsor
- Johnson & Johnson Pharmaceutical Research & Development, L.L.C.
- Status
- COMPLETED
- Phase
- Phase 3
- Study type
- INTERVENTIONAL
- Start date
- 1998-05-01
- Enrollment
- 49
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.